Psilocybin Attenuates Cortical Representations of Aversion in the Mouse Auditory Cortex

Using longitudinal two-photon calcium imaging in awake mice, this study demonstrates that psilocybin selectively attenuates cortical representations of well-consolidated aversive stimuli and their associated cues in the auditory cortex, without disrupting new aversive learning or reward processing.

The Gist

The Big Idea: How Magic Mushrooms "Reset" Bad Memories in the Brain

Imagine your brain is like a massive, bustling library. Inside this library, there are specific shelves dedicated to sounds (the Auditory Cortex). Usually, this library is very good at organizing books by their title (the pitch of a sound). But, this library also has a special section where it tags books with emotional labels.

For example, if you hear a siren and immediately get scared because it means danger, your brain writes a sticky note on that sound: "DANGER!" Over time, that sticky note gets thick, heavy, and hard to remove. This is how we form bad associations, like the fear a trauma survivor feels when hearing a specific sound.

Psilocybin (the active ingredient in "magic mushrooms") is often used to help people with depression and PTSD. Scientists knew it helped people feel better, but they didn't know how it changed the brain's library. Did it burn the bad books? Did it just tear off the sticky notes? Or did it rearrange the whole shelf?

This study used high-tech cameras to watch individual brain cells in mice as they listened to sounds, some of which were linked to bad experiences. Here is what they found:

1. The Experiment: The "Scary Sound" Training

The researchers taught mice to associate a specific tone (a beep) with a mild, annoying puff of air to their face.

• The Result: The mice's brain cells started firing wildly whenever they heard that specific beep. The "Danger" sticky note was firmly attached.
• The Control: They also had a tone that was just a neutral beep, and a tone linked to a drop of water (a reward).

2. The Treatment: The Psilocybin "Reset"

The mice were then given a dose of psilocybin. The researchers watched their brains immediately after and then again days later.

The Discovery: It's a "Selective Eraser," not a "Blender"
The most surprising finding was that psilocybin didn't just scramble everything. It was incredibly precise:

• Old Bad Memories: When the mice heard the old scary beep (the one they learned a week ago), their brain cells stopped reacting so strongly. The "Danger" sticky note was effectively peeled off.
• New Bad Memories: If they tried to teach the mice a new scary sound immediately after the drug, the brain learned it just fine. The drug didn't stop them from learning new things.
• Good Memories: The brain cells still reacted normally to the "reward" sound (water). The drug didn't turn off the happy parts of the brain.
• Neutral Sounds: The brain still heard regular beeps perfectly fine. It didn't turn the mice deaf or confused.

The Analogy:
Imagine your brain is a radio station.

• Before the drug: The "Fear Station" is blasting at maximum volume, drowning out everything else.
• After the drug: Psilocybin didn't smash the radio or turn off the power. Instead, it quietly turned the volume down only on the specific channel that was playing the old, scary song. The other channels (music, news, happy sounds) kept playing loud and clear.

3. The "Group Hug" vs. The "Solo Act"

The researchers also looked at how the brain cells talked to each other.

• Immediately after the drug: The brain cells seemed to get very excited and coordinated, almost like a group of people suddenly holding hands and dancing together. This is the "acute" phase where everything feels different.
• A few days later: For the cells dealing with the old scary sound, this group coordination broke down. They stopped acting like a synchronized team. This suggests that the strong, rigid link between the sound and the fear was loosened, allowing the brain to stop treating that sound as a threat.

4. Why This Matters

This is huge news for mental health.

• The Problem: Many people with PTSD or depression are stuck in a loop where their brain is stuck on "Fear Mode." They can't unlearn these associations because the "sticky notes" are too strong.
• The Solution: This study suggests psilocybin acts like a specialized eraser. It targets the consolidated (old, strong) bad memories and weakens them, but it leaves the brain's ability to learn new things and feel happy completely intact.

The Bottom Line

Psilocybin doesn't just "mess up" the brain. It acts like a surgical tool for emotional memories. It specifically dampens the brain's reaction to old, painful associations without messing up your ability to hear, learn new things, or feel joy.

It's as if the drug tells your brain: "Hey, that old scary story you've been telling yourself? You don't need to believe it anymore. Let's turn down the volume on that one, so you can hear the rest of the world again."

Technical Summary

1. Problem Statement

Psilocybin has demonstrated sustained therapeutic benefits for affective disorders (e.g., depression, PTSD) and trauma-related conditions, often persisting long after the drug's pharmacokinetics have cleared. However, the neural mechanisms underlying how psilocybin reshapes sensory representations of learned valence associations remain unclear. Specifically, it is unknown whether psilocybin:

• Selectively dampens established negative emotional memories versus new associations.
• Modulates sensory cortices (like the auditory cortex) directly or indirectly via limbic inputs.
• Alters population-level neural coordination (noise correlations) in response to aversive cues.

While previous studies have focused on frontal and limbic regions, sensory cortices are increasingly recognized as sites of emotional integration. This study aims to fill the gap by examining how psilocybin modulates single-cell and population-level activity in the mouse auditory cortex (A1) in response to tones paired with aversive or rewarding stimuli.

2. Methodology

The study utilized longitudinal two-photon calcium imaging in awake, head-fixed C57BL/6J mice to track the same neurons over weeks.

• Subjects & Preparation: 33 mice were implanted with cranial windows over the right auditory cortex and injected with AAV-syn-GCaMP8f to label Layer 2/3 neurons.
• Stimuli:
  • Auditory: Pure tones (4, 8, 13, 22 kHz).
  • Valence: Water (reward) and Air Puff (aversive, 15 PSI directed at the eye).
• Experimental Paradigms:
  1. Reward/Aversive Dataset (Acute): Mice were trained to associate specific tones with water or air puffs. They were imaged before (Pre) and shortly after (Post, within 35 mins) an intraperitoneal injection of Psilocybin (2 mg/kg) or Saline.
  2. Aversive-Only Longitudinal Dataset:
     • Week 1: Tone 1 (9 kHz) was paired with air puffs (establishing a consolidated aversive memory).
     • Week 2 (Injection Day): Mice received Psilocybin or Saline. Imaging occurred Pre-injection, and Post-injection (10–35 mins). Immediately after imaging, a new tone (Tone 3, 22 kHz) was paired with air puffs to test new learning. Tone 2 (13 kHz) remained unpaired.
     • Follow-up: Imaging was repeated at Post+1 (24 hours) and Post+8 (8 days) to assess persistence.
• Data Analysis:
  • Cellular Level: Deconvolved spike rates, Peri-stimulus time histograms (PSTHs), and response categorization (tone-only, stimulus-only, dual-responsive).
  • Population Level: Noise correlation analysis (trial-to-trial co-variability) and Compositional Data Analysis (CoDa) to track shifts in response category distributions.
  • Behavioral Control: DeepLabCut video analysis tracked locomotion, blink amplitude, and facial motion to rule out behavioral confounds.

3. Key Contributions

• Longitudinal Single-Cell Tracking: The study provides high-resolution data on how specific neuronal ensembles in the auditory cortex evolve over weeks following psychedelic administration, distinguishing between acute and long-term effects.
• Valence-Specific Modulation: It demonstrates that psilocybin does not globally suppress auditory processing but selectively targets representations of established aversive associations.
• Differentiation of Memory States: The research distinguishes between the effects of psilocybin on consolidated memories (formed 1 week prior) versus new associations formed during or immediately after the drug state.
• Network Dynamics: It reveals a biphasic effect on population coordination: an acute increase in global noise correlation followed by a selective reduction in coordination specifically among neurons encoding aversive associations.

4. Key Results

A. Selective Attenuation of Aversive Responses

• Aversive Stimuli: Psilocybin significantly reduced spike rates evoked by air puffs and tones previously paired with air puffs (consolidated aversive memory).
• Reward/Neutral Stimuli: Responses to water (reward) and unpaired tones were not significantly altered by psilocybin compared to saline controls.
• New Associations: Tones paired with air puffs immediately after psilocybin injection (within 35 mins) showed no significant reduction in response compared to saline, indicating psilocybin does not block the formation of new aversive associations in the acute phase.

B. Population-Level Coordination (Noise Correlation)

• Acute Phase (Post): Psilocybin caused a transient, global increase in noise correlation across all tone-responsive neurons, suggesting a state of heightened, diffuse synchrony.
• Delayed Phase (Post+1/Post+8): In the days following injection, noise correlation decreased selectively among neurons encoding the previously aversive-associated tone. This suggests a "decoupling" or weakening of the specific neural ensemble representing the negative memory.

C. Neuronal Subpopulations

• Response Categories: Psilocybin did not change the overall proportion of tone-only vs. stimulus-only neurons immediately. However, over 8 days, there was a relative increase in the proportion of "tone-only" neurons in the psilocybin group, while "puff-only" (aversive) neurons showed a significant reduction in evoked spike rates.
• Specificity: The attenuation was most pronounced in neurons that responded only to the aversive stimulus (puff-only), suggesting a targeted dampening of aversive drive.

D. Behavioral Controls

• No significant differences were found in locomotion, blink reflexes, or facial motion between psilocybin and saline groups, confirming that neural changes were not artifacts of altered arousal or motor behavior.

5. Significance and Implications

• Mechanism of Action: The findings support the hypothesis that psilocybin preferentially dampens well-consolidated negative affective representations rather than broadly disrupting sensory processing or preventing new learning. This aligns with the "Relaxed Beliefs Under Psychedelics" (REBUS) model, where strong priors (consolidated memories) are temporarily loosened.
• Therapeutic Relevance: The selective attenuation of established aversive memories without affecting new learning or basic auditory function offers a mechanistic explanation for psilocybin's efficacy in treating chronic conditions like PTSD and depression, where maladaptive memories are resistant to standard therapy.
• Safety Profile: The data suggests that transient negative experiences occurring during the psychedelic state (e.g., "bad trips") are not preferentially strengthened or permanently encoded in the sensory cortex, supporting the safety of psilocybin-assisted psychotherapy regarding the formation of new trauma.
• Future Directions: The study highlights the need to investigate specific cell types (e.g., excitatory vs. inhibitory, deep vs. superficial layers) and the role of long-range inputs from the amygdala and prefrontal cortex in mediating these effects.

In conclusion, this paper provides robust evidence that psilocybin acts as a selective modulator of aversive sensory representations in the auditory cortex, dampening consolidated negative memories while preserving the integrity of basic sensory processing and the capacity for new learning.